These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 37107632

  • 21. Decoding the genetic influence of CT60 non-coding polymorphism in CTLA-4 gene and sCTLA-4 biomarker with rheumatoid arthritis in the Indian population.
    Shamala V, Asha Devi S.
    Mol Biol Rep; 2024 Sep 28; 51(1):1023. PubMed ID: 39340674
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evaluation of CTLA-4 (+ 49A/G) polymorphism association with rheumatoid arthritis in Egyptian patients.
    Ragab D, Hammoda RM, El-Gharbawy NH, Salem R.
    Egypt J Immunol; 2023 Jul 28; 30(3):180-189. PubMed ID: 37440667
    [Abstract] [Full Text] [Related]

  • 25. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
    Zhu CL, Huang Q, Liu CH, Xie F.
    Mol Biol Rep; 2012 Sep 28; 39(9):8701-8. PubMed ID: 22711308
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis.
    Li X, Zhang C, Zhang J, Zhang Y, Wu Z, Yang L, Xiang Z, Qi Z, Zhang X, Xiao X.
    J Clin Immunol; 2012 Jun 28; 32(3):530-9. PubMed ID: 22354566
    [Abstract] [Full Text] [Related]

  • 29. Cytotoxic T-lymphocyte antigen 4 gene polymorphism influences the incidence of symptomatic human cytomegalovirus infection after renal transplantation.
    Misra MK, Pandey SK, Kapoor R, Sharma RK, Agrawal S.
    Pharmacogenet Genomics; 2015 Jan 28; 25(1):19-29. PubMed ID: 25356901
    [Abstract] [Full Text] [Related]

  • 30. Strong association of CTLA-4 variation (CT60A/G) and CTLA-4 haplotypes with predisposition of Iranians to head and neck cancer.
    Erfani N, Haghshenas MR, Hoseini MA, Hashemi SB, Khademi B, Ghaderi A.
    Iran J Immunol; 2012 Sep 28; 9(3):188-98. PubMed ID: 23023383
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
    Zhang C, Hou WH, Ding XX, Wang X, Zhao H, Han XW, Wang WJ.
    Asian Pac J Cancer Prev; 2016 Sep 28; 17(8):3785-91. PubMed ID: 27644617
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Karabon L, Markiewicz M, Partyka A, Pawlak-Adamska E, Tomkiewicz A, Dzierzak-Mietla M, Kyrcz-Krzemien S, Frydecka I.
    Immunogenetics; 2015 Jun 28; 67(5-6):295-304. PubMed ID: 25940108
    [Abstract] [Full Text] [Related]

  • 35. The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves' disease in the Chinese population.
    Du L, Yang J, Huang J, Ma Y, Wang H, Xiong T, Xiang Z, Zhang Y, Huang J.
    BMC Med Genet; 2013 Apr 19; 14():46. PubMed ID: 23597029
    [Abstract] [Full Text] [Related]

  • 36. HCV F protein amplifies the predictions of IL-28B and CTLA-4 polymorphisms about the susceptibility and outcomes of HCV infection in Southeast China.
    Xiao W, Zhang Q, Deng XZ, Jiang LF, Zhu DY, Pei JP, Ge CY, Li BJ, Wang CJ, Zhang JH, Zhou ZX, Ding WL, Xu XD, Yue M.
    Infect Genet Evol; 2015 Aug 19; 34():52-60. PubMed ID: 26079279
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.
    Banelli B, Morabito A, Laurent S, Piccioli P, Dozin B, Ghio M, Ascierto PA, Monteghirfo S, Marasco A, Ottaviano V, Queirolo P, Romani M, Pistillo MP.
    Hum Immunol; 2014 Aug 19; 75(8):730-9. PubMed ID: 24801647
    [Abstract] [Full Text] [Related]

  • 39. CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis.
    Wang K, Zhu Q, Lu Y, Lu H, Zhang F, Wang X, Fan Y.
    Genet Test Mol Biomarkers; 2017 Apr 19; 21(4):222-227. PubMed ID: 28384040
    [Abstract] [Full Text] [Related]

  • 40. The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.
    Song GG, Kim JH, Lee YH.
    Mol Biol Rep; 2013 Apr 19; 40(4):2985-93. PubMed ID: 23264102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.